See also this year's filing and all EDGAR filings for this company.
PDF Report 0001384101_2020_Veracyte_INC.pdf
Logs
info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.3713075255718969, 'aggregate_val': 153101000, 'exp_sum': 111646000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 36729000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 0, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 52389000, 'ResearchAndDevelopmentExpense': 17204000, 'remainder_Expenses': 5324000}} |
Graph
Absolute values for 0001384101, Veracyte INC
xvar | xval | |
---|---|---|
0 | IntangibleAssets | 2,725,000 |
1 | AssetsNonCurrent | 10,245,000 |
2 | AssetsCurrent | 187,687,000 |
3 | PropertyPlantAndEquipment | 8,933,000 |
4 | remainder_Assets | 65,622,000 |
5 | LongTermLiabilities | 12,200,000 |
6 | LiabilitiesCurrent | 17,469,000 |
7 | remainder_Liabilities | 6,088,000 |
8 | LaborExpense | 0 |
9 | CostOfGoodsAndServicesSold | 36,077,000 |
10 | GeneralAndAdministrativeExpense | 29,029,000 |
11 | GoodwillImpairmentLoss | 0 |
12 | OperatingCostsAndExpenses | 0 |
13 | DepreciationDepletionAndAmortization | 0 |
14 | SellingAndMarketingExpense | 53,691,000 |
15 | ResearchAndDevelopmentExpense | 14,851,000 |
16 | remainder_Expenses | 1,847,000 |
17 | remainder_Revenues | 120,368,000 |
18 | remainder_NetIncome | 0 |
19 | remainder_ComprehensiveNetIncome | 2,528,000 |
yvar | yval | |
---|---|---|
0 | Assets | 275,212,000 |
1 | Liabilities | 35,757,000 |
2 | Expenses | 135,495,000 |
3 | Revenues | 120,368,000 |
4 | StockholdersEquity | 239,455,000 |
5 | NetIncome | -15,127,000 |
6 | ComprehensiveNetIncome | -12,599,000 |
7 | BaseVar | 284,680,000 |
8 | EconomicCapitalRatio | 4.20 |